Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716

Neuropharmacology

Volumn 47, Issue 8, 2004, Pages 1157-1169

  Singh, M E ^a   Verty, A N A ^a   Price, I ^a   McGregor, I S ^b   Mallet, P E ^a  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cannabinoid; Immunochemistry; Locomotion; Morphine; Opioid; Rat; SR 141716; Thermoregulation

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; DRUG VEHICLE; MORPHINE; OPIATE RECEPTOR; PROTEIN FOS; RIMONABANT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; ATTENUATION; BODY TEMPERATURE; BRAIN REGION; CAUDATE NUCLEUS; CELL ACTIVATION; CHEMICAL INTERACTION; CINGULATE GYRUS; CONTROLLED STUDY; HYPOTHALAMUS NUCLEUS; IMMUNOREACTIVITY; INJECTION; INSULA; LOCOMOTION; MALE; MODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PERFUSION; PERIAQUEDUCTAL GRAY MATTER; PREOPTIC NUCLEUS; PRIORITY JOURNAL; PUTAMEN; PYRIFORM CORTEX; RAT; RAT STRAIN; STRIA TERMINALIS; THALAMUS NUCLEUS; VENTRAL TEGMENTUM; ZONA INCERTA;

ANIMALS; CANNABINOIDS; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE; MOTOR ACTIVITY; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID;

EID: 9644275522     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.08.008     Document Type: Article

References (80)

1. Adler M.W., Gellar E.B. Physiological functions of opioids: temperature regulation. Herz A., Akil H., Simon E.J. Handbook of Experimental Pharmacology. 1993;205-238 Springer-Verlag, Berlin
2. Alheid G., De Olmos J.E., Beltramino C.A. Amygdala and extended amygdala. Paxinos G. The Rat Nervous System. 1995;495-578 Academic Press, New York
3. 9-THC induced Fos expression in rat brain. Neuropharmacology. 44:2003;264-274
4. 2 function. Neuroscience. 91:1999;607-620
5. Ameri A. The effects of cannabinoids on the brain. Progress in Neurobiology. 58:1999;315-348
6. Arnold J.C., Topple A.N., Mallet P.E., Hunt G.E., McGregor I.S. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Research. 921:2001;240-255
7. Bachtell R.K., Tsivkovskaia N.O., Ryabinin A.E. Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal tranduction mechanisms. Journal of Pharmacology. 302:2002;516-524
8. Bachtell R.K., Tsivkovskaia N.O., Ryabinin A.E. Identifications of temperature-sensitive neural circuits in mice using c-Fos expression mapping. Brain Research. 960:2003;157-164
9. Benamar K., Xin L., Gellar E.B., Adler M.W. Effects of central and peripheral administration of a nitric oxide synthase inhibitor on morphine hyperthermia in rats. Brain Research. 894:2001;266-273
10. Braida D., Pozzi M., Cavallini R., Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience. 104:2001;923-926
11. Cador M., Rivet J.M., Kelley A.E., Le Moal M., Stinus L. Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study of dopamine turnover in several forebrain structures. Brain Research. 486:1989;357-363
12. Chang S.L., Squinto S.P., Harlan R.E. Morphine activation of c-Fos expression in rat brain. Biochemical and Biophysical Research Communication. 157:1988;698-704
13. 1) receptors in the establishment of place conditioning in rats. Psychopharmacology. 135:1998;324-332
14. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology. 102:1990;156-162
15. Chen X.-H., Geller E.B., DeRiel L., Liu-Shen L.-Y., Adler M.W. Antisense oligodeoxynucleotides against μ- or κ-opioid receptors block agonist-induced body temperature changes in rats. Brain Research. 688:1995;237-241
16. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. Journal of Neuroscience. 23:2003;9445-9451
17. Cichewicz D.L. Synergistic interactions between cannabinoid and opioid analgesics. Life Sciences. 74:2004;1317-1324
18. 1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behavioural Pharmacology. 13:2002;451-463
19. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sciences. 63:1998;L113-PL117
20. 9- Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. European Journal of Pharmacology. 323:1997;193-195
21. Crown E.D., King T.E., Meagher M.W., Grau J.W. Shock-induced hyperalgesia: III. Role of the bed nucleus of the stria terminalis and amygdaloid nuclei. Behavioural Neuroscience. 114:2000;561-573
22. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety? Biological Psychiatry. 44:1998;1239-1247
23. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental μ, ∂, and κ opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis study. Journal of Pharmacology and Experimental Therapeutics. 266:1993;1236-1246
24. Elmquist J.K., Elias C., Saper C. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 22:1998;221-232
25. Erdtmann-Vourliotis M., Mayer P., Linke R., Riechert U., Hollt V. Long-lasting sensitization towards morphine in motoric and limbic areas as determined by c-Fos expression in rat brain. Molecular Brain Research. 72:1999;1-16
26. Fant R.V., Heishman S.J., Bunker E.B., Pickworth W.B. Acute and residual effects of marijuana in humans. Pharmacology Biochemistry and Behavior. 60:1998;777-784
27. 9-tetrahydrocannabinol. British Journal of Pharmacology. 75:1982;409-414
28. Frankel P.S., Garcia M.M., Harlan R.E. Infusion of β-FNA into the thalamus attenuates morphine-induced c-Fos induction in the rat caudate putamen. Brain Research. 838:1999;222-226
29. 1 receptor agonist. European Journal of Pharmacology. 370:1999;233-240
30. Garcia M.M., Brown H.E., Harlan R.E. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Research. 692:1995;23-40
31. 9- tetrahydrocannabinol. Psychopharmacology. 96:1988;142-144
32. 1 cannabinoid receptor on anxiety. European Journal of Neuroscience. 16:2002;1395-1398
33. Harlan R.E., Garcia M.M. Drugs of abuse and immediate-early genes in the forebrain. Molecular Neurobiology. 16:1998;221-267
34. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabiniod receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience. 11:1991;563-583
35. 1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. Journal of Neurochemistry. 84:2003;698-704
36. Innis R.B., Aghajanian G.K. Cholecystokinin-containing and nociceptive neurons in rat Edinger-Westphal nucleus. Brain Research. 363:1986;230-238
37. Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. British Journal of Pharmacology. 134:2001;1151-1154
38. Jekab R.L., Leranth C. Septum. Paxinos G. The Rat Nervous System. 1995;405-442 Academic Press, New York
39. Kang W., Wilson S.P., Wilson M.A. Overexpression of proencephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines. Neuropsychopharmacology. 22:2000;77-88
40. Kirkham T.C., Williams C.M. Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology. 153:2001;267-270
41. 9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain. Brain Research. 525:1990;78-83
42. Lichtman A.H., Cook S.A., Martin B.R. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periacqueductal gray involvement. Journal of Pharmacology and Experimental Therapeutics. 276:1996;585-593
43. 1 and N-methyl-D-aspartate receptors. Proceedings of the National Academy of Science, USA. 91:1994;8537-8541
44. Mansour A. Anatomy of CNS opioid receptors. Trends in Neuroscience. 11:1988;308-314
45. Manzanares J., Corchero J., Romero J., Fernández-Ruiz J.J., Ramos J.A., Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends in Pharmacological Sciences. 20:1999;287-294
46. Maruyama M., Nishi M., Konishi M., Takashige Y., Nagashima K., Kiyohara T., Kanosue K. Brain regions expressing Fos during thermoregulatory behavior in rats. American Journal of Physiology. 285:2003;R1116-R1123
47. McGregor I.S., Issakidis C.N., Prior G. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacology Biochemistry and Behavior. 53:1996;657-664
48. Morley K.C., Gallate J.E., Hunt G.E., Mallet P.E., McGregor I.S. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxy methamphetamine ("ecstasy"). European Journal of Pharmacology. 433:2001;91-99
49. Navarro M., Carrera M.R., Fratta W., Valverde O., Cossu G., Fattore L., Chowen J.A., Gomez R., del Arco I., Villanua M.A., Maldonado R., Koob G.F., de Fonseca F.R. Functional interaction between opioid and cannabinoid receptors in drug self-administration. Journal of Neuroscience. 21:2001;5344-5350
50. Norwood C.S., Cornish J.L., Mallet P.E., McGregor I.S. Pre-exposure to the cannabinoid receptor agonist CP 55, 940 enhances morphine behavioral sensitization and alters morphine self-administration in lewis rats. European Journal of Pharmacology. 465:2003;105-114
51. Onaivi E.S., Green M.R., Martin B.R. Pharmacological characterization of cannabinoids in the elevated plus maze. Journal of Pharmacology and Experimental Therapeutics. 253:1990;1002-1009
52. Pakulska W., Wejman I., Czarnecka E. Influence of felbamate on the antinociceptive action of morphine, metamizol and indomethacin in mice. Acta Poloniae Pharmaceutica. 60:2003;201-206
53. Park T.H., Carr K.D. Neuroanatomical patterns of Fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline- and naltrexone-treated rats. Brain Research. 805:1998;169-180
54. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press
55. 9-tetrahydrocannabinol in enhanced by chloropromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpride. Neuropharmacology. 27:1988;149-155
56. Pomonis J.D., Jewett D.C., Kotz C.M., Briggs J.E., Billington C.J., Levine A.S. Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain. American Journal of Physiology. 278:2000;R712-R729
57. 9-tetrahydrocannabinol-induced antinociception in mice. Neuropharmacology. 37:1998;215-222
58. Rodgers R.J., Haller J., Halasz J., Mikics E. 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR 141716 in the mouse elevated plus-maze. European Journal of Neuroscience. 17:2003;1279-1286
59. 1 receptor antagonist, influences morphine withdrawal syndrome. Life Sciences. 66:2000;2213-2219
60. Scammell T.E., Price K.J., Sagar S.M. Hyperthermia induces c-Fos expression in the preoptic area. Brain Research. 618:1993;303-307
61. Shu S.Y., Ju G., Fan L.Z. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neuroscience Letters. 85:1988;169-171
62. Simantov R., Childers S.R., Snyder S.H. The opiate receptor binding interaction of 3H-methionin enkephalin, an opiate receptor peptide. European Journal of Pharmacology. 47:1978;319-331
63. Singh M.E., Warty N.A., McGregor I.S., Mallet P.E. The CB1 receptor antagonist SR 141716 blocks the establishment of conditioned place preference but not locomotor sensitisation to morphine. 31st Annual Meeting of the Society for Neuroscience:2001;333 Society for Neuroscience, San Diego, CA, USA
64. 9-tetrahydrocannabinol. Pharmacology Biochemistry and Behavior. 60:1998;559-566
65. Stevens K.E., Mickley G.A., McDermott L.J. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57Bl/6J mouse. Pharmacology Biochemistry and Behavior. 24:1986;1739-1747
66. Sulcova E., Mechoulam R., Fride E. Biphasic effects of anandamide. Pharmacology Biochemistry and Behavior. 59:1998;347-352
67. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organisation of the paraventricular and supraoptic nuclei. Annual Review of Neuroscience. 6:1983;269-324
68. Tepperman F.S., Hirst M. Concerning the specificity of the hypothalamic opiate receptor responsible for food intake in the rat. Pharmacology Biochemistry and Behavior. 17:1982;1141-1144
69. 9- tetrahydrocannabinol on hypothalamically induced feeding. Psychopharmacology (Berl). 103:1991;172-176
70. Trzcinka G.P., Lipton J.M., Hawkins M., Clark W.G. Effects on temperature of morphine injected into the preoptic/anterior hypothalamus, medulla oblongata, and peripherally in unrestrained and restrained rats. Proceedings of the Society for Experimental Biology and Medicine. 156:1977;523-526
71. 9-tetrahydrocannabinol in rats. European Journal of Pharmacology. 70:1981;219-224
72. 1 receptor antagonist, SR 141716. European Journal of Pharmacology. 445:2002;55-59
73. Verty A.N.A., McGregor I.S., Mallet P.E. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neuroscience Letters. 354:2004;217-220
74. Verty A.N.A., Singh M.E., McGregor I.S., Mallet P.E. Interactive effects on food intake by cannabinoid and opioid receptors in the paraventricular hypothalamic nucleus. 20th International Australasian Winter Conference on Brain Research, Queenstown, New Zealand:2002
75. Verty A.N.A., Singh M.E., McGregor I.S., Mallet P.E. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology. 168:2003;314-323
76. Welch S.P., Eads M. Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Research. 848:1999;183-190
77. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine in mice. Journal of Pharmacology and Experimental Therapeutics. 262:1992;10-18
78. Wenger T., Moldrich G. The role of endocannabinoids in the hypothalamic regulation of visceral function. Prostaglandins Leukotrienes and Essential Fatty Acids. 66:2002;301-307
79. 9-THC hyperphagia by SR 141716 and naloxone but not dexfenfluramine. Pharmacology Biochemistry and Behavior. 71:2002;341-348
80. Williams G., Bing C., Cai X.J., Harrold J.A., King P.J., Liu X.H. The hypothalamus and the control of energy homeostasis. Different circuits, different purposes. Physiology and Behavior. 74:2001;683-701